It should also be noted that MYCN expression is down regulated in neuroblastoma cells after treatment with RA [2], so if PPARδ1 expression is repressed directly or indirectly by MYCN, its potential up-regulation in response to RA would act as a compensatory cell-survival and cell-growth mechanism. The gene discussed is MYCN; the disease is neuroblastoma.